66 related articles for article (PubMed ID: 15993511)
1. The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells.
Oguri T; Achiwa H; Bessho Y; Muramatsu H; Maeda H; Niimi T; Sato S; Ueda R
Lung Cancer; 2005 Sep; 49(3):345-51. PubMed ID: 15993511
[TBL] [Abstract][Full Text] [Related]
2. Germline
Zhang T; Ambrodji A; Huang H; Bouchonville KJ; Etheridge AS; Schmidt RE; Bembenek BM; Temesgen ZB; Wang Z; Innocenti F; Stroka D; Diasio RB; Largiadèr CR; Offer SM
Elife; 2024 Apr; 13():. PubMed ID: 38686795
[TBL] [Abstract][Full Text] [Related]
3. The Critical Function of microRNAs in Developing Resistance against 5- Fluorouracil in Cancer Cells.
Sheikhnia F; Maghsoudi H; Majidinia M
Mini Rev Med Chem; 2024; 24(6):601-617. PubMed ID: 37642002
[TBL] [Abstract][Full Text] [Related]
4.
Kang YH; Lee JS; Lee NH; Kim SH; Seo CS; Son CG
Molecules; 2021 Mar; 26(7):. PubMed ID: 33806077
[TBL] [Abstract][Full Text] [Related]
5. Expression of thymidylate synthase in human non-small cell lung cancer.
Otake Y; Tanaka F; Yanagihara K; Hitomi S; Okabe H; Fukushima M; Wada H
Jpn J Cancer Res; 1999 Nov; 90(11):1248-53. PubMed ID: 10622537
[TBL] [Abstract][Full Text] [Related]
6. Sorivudine and 5-fluorouracil; a clinically significant drug-drug interaction due to inhibition of dihydropyrimidine dehydrogenase.
Diasio RB
Br J Clin Pharmacol; 1998 Jul; 46(1):1-4. PubMed ID: 9690942
[TBL] [Abstract][Full Text] [Related]
7. Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment.
Azwar S; Seow HF; Abdullah M; Faisal Jabar M; Mohtarrudin N
Biology (Basel); 2021 Aug; 10(9):. PubMed ID: 34571731
[TBL] [Abstract][Full Text] [Related]
8. Elevated PAF1-RAD52 axis confers chemoresistance to human cancers.
Rauth S; Ganguly K; Atri P; Parte S; Nimmakayala RK; Varadharaj V; Nallasamy P; Vengoji R; Ogunleye AO; Lakshmanan I; Chirravuri R; Bessho M; Cox JL; Foster JM; Talmon GA; Bessho T; Ganti AK; Batra SK; Ponnusamy MP
Cell Rep; 2023 Feb; 42(2):112043. PubMed ID: 36709426
[TBL] [Abstract][Full Text] [Related]
9. The Clinical Significance of Promoter Methylation of Fluoropyrimidine Metabolizing and Cyclooxygenase Genes in Colorectal Cancer.
Fouad MA; Salem SE; Hussien MM; Badr DM; Zekri AN; Hafez HF; Shouman SA
Epigenet Insights; 2021; 14():2516865720986231. PubMed ID: 33644686
[TBL] [Abstract][Full Text] [Related]
10. Gene-expression data integration to squamous cell lung cancer subtypes reveals drug sensitivity.
Wu D; Pang Y; Wilkerson MD; Wang D; Hammerman PS; Liu JS
Br J Cancer; 2013 Sep; 109(6):1599-608. PubMed ID: 24002593
[TBL] [Abstract][Full Text] [Related]
11. Targeting CCR3 with antagonist SB 328437 sensitizes 5‑fluorouracil‑resistant gastric cancer cells: Experimental evidence and computational insights.
Gutiérrez Á; Reyes ME; Larronde C; Brebi P; Mora-Lagos B
Oncol Lett; 2024 Jul; 28(1):296. PubMed ID: 38737977
[TBL] [Abstract][Full Text] [Related]
12. The relationship between tumor metabolism and 5-fluorouracil resistance.
Hu J; Li A; Guo Y; Ma T; Feng S
Biochem Pharmacol; 2023 Dec; 218():115902. PubMed ID: 37922975
[No Abstract] [Full Text] [Related]
13. SEZ6L2 Is an Important Regulator of Drug-Resistant Cells and Tumor Spheroid Cells in Lung Adenocarcinoma.
Lee JS; Kim HY; Won B; Kang SW; Kim YN; Jang H
Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33202873
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Structure-Activity Relationship in the Series of 5-Ethyluridine, N2-Guanine, and 6-Oxopurine Derivatives with Pronounced Anti-Herpetic Activity.
Khairullina V; Martynova Y
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067446
[TBL] [Abstract][Full Text] [Related]
15. 7-Geranyloxycinnamic Acid Isolated from
Eliaser EM; Mohd Hashim N; Rukayadi Y; Abdull Razis AF
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110846
[TBL] [Abstract][Full Text] [Related]
16. Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect.
Narendra G; Choudhary S; Raju B; Verma H; Silakari O
Clin Pharmacokinet; 2022 Nov; 61(11):1495-1517. PubMed ID: 36180817
[TBL] [Abstract][Full Text] [Related]
17. Safety of apatinib plus S-1 for advanced solid tumor as palliative treatment.
Chen S; Sun J; Zhao L; Sun Y; Jia D; Song Y; Luo J; Lei H; Liu N
Exp Ther Med; 2021 Jan; 21(1):62. PubMed ID: 33365062
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors sensitize 5-fluorouracil-resistant MDA-MB-468 breast cancer cells to 5-fluorouracil.
Minegaki T; Suzuki A; Mori M; Tsuji S; Yamamoto S; Watanabe A; Tsuzuki T; Tsunoda T; Yamamoto A; Tsujimoto M; Nishiguchi K
Oncol Lett; 2018 Nov; 16(5):6202-6208. PubMed ID: 30333885
[TBL] [Abstract][Full Text] [Related]
19. The relationship between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase, excision repair cross-complementation group 1 and class III β-tubulin, and the therapeutic effect of S-1 or carboplatin plus paclitaxel in non-small-cell lung cancer.
Okuda K; Tatematsu T; Yano M; Nakamae K; Yamada T; Kasugai T; Nishida T; Sano M; Moriyama S; Haneda H; Kawano O; Sakane T; Oda R; Watanabe T; Nakanishi R
Mol Clin Oncol; 2018 Jul; 9(1):21-29. PubMed ID: 29977535
[TBL] [Abstract][Full Text] [Related]
20. Chemoresistance to Cancer Treatment: Benzo-α-Pyrene as Friend or Foe?
Dzobo K; Hassen N; Senthebane DA; Thomford NE; Rowe A; Shipanga H; Wonkam A; Parker MI; Mowla S; Dandara C
Molecules; 2018 Apr; 23(4):. PubMed ID: 29673198
[No Abstract] [Full Text] [Related]
[Next] [New Search]
